Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Recombinant Human Papillomavirus 9-Valent Vaccine Supply, Demand and Key Producers, 2024-2030

date 11 Feb 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Papillomavirus 9-Valent Vaccine

The global Recombinant Human Papillomavirus 9-Valent Vaccine market size is expected to reach $ 2554.7 million by 2030, rising at a market growth of 4.8% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Human Papillomavirus 9-Valent Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Papillomavirus 9-Valent Vaccine

According to our (Global Info Research) latest study, the global Recombinant Human Papillomavirus 9-Valent Vaccine market size was valued at USD 1841.8 million in 2023 and is forecast to a readjusted size of USD 2554.7 million by 2030 with a CAGR of 4.8% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Papillomavirus 9-Valent Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Pharma & Healthcare

new_biaoQian Recombinant Human Papillomavirus 9-Valent Vaccine

According to our (Global Info Research) latest study, the global Recombinant Human Papillomavirus 9-Valent Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Papillomavirus 9-Valent Vaccine Supply, Demand and Key Producers, 2023-2029

date 26 Jan 2023

date Pharma & Healthcare

new_biaoQian Recombinant Human Papillomavirus 9-Valent Vaccine

The global Recombinant Human Papillomavirus 9-Valent Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

The global Recombinant Human Papillomavirus 9-Valent Vaccine market size is expected to reach $ 2554.7 million by 2030, rising at a market growth of 4.8% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

According to our (Global Info Research) latest study, the global Recombinant Human Papillomavirus 9-Valent Vaccine market size was valued at USD 1841.8 million in 2023 and is forecast to a readjusted size of USD 2554.7 million by 2030 with a CAGR of 4.8% during review period.

USD3480.00

addToCart

Add To Cart

According to our (Global Info Research) latest study, the global Recombinant Human Papillomavirus 9-Valent Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

addToCart

Add To Cart

The global Recombinant Human Papillomavirus 9-Valent Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart